Literature DB >> 33413668

Bleomycin induces fibrotic transformation of bone marrow stromal cells to treat height loss of intervertebral disc through the TGFβR1/Smad2/3 pathway.

Xiao Yang1, Zhiqian Chen1, Chen Chen1, Chen Han1, Yifan Zhou1, Xunlin Li1, Haijun Tian1, Xiaofei Cheng1, Kai Zhang1, An Qin2, Tangjun Zhou3, Jie Zhao4.   

Abstract

BACKGROUND: Lower back pain is often accredited to loss of intervertebral disc (IVD) height and compromised spine stability as a result of intervertebral disc degeneration (IVDD). We aim to locally use bleomycin to induce the fibrotic transformation of bone marrow stromal cells (BMSCs) as a means to induce reparative fibrosis to slow down the height loss.
METHODS: IVDs from patients were gathered for histological examination. The expression of the transforming growth factor beta 1 (TGF-β) signaling pathway was determined by qPCR and western blotting. Nucleus pulposus (NP) cells, annulus fibrosus (AF) cells, and the rats' bone marrow stromal cells (BMSC) were cultured and their responsiveness to bleomycin was evaluated by Cell Counting Kit-8, comet assay, transwell migration, and wound healing assays. Rat IVDD models were created by puncture and rescued by bleomycin injection, and the effectiveness was evaluated by images (X-ray and MRI) and atomic force microscope.
RESULTS: Histological examination showed increased levels of pro-fibrotic markers in IVDD tissues from patients. AF cells and BMSC cells were induced to adopt a pro-fibrotic phenotype with increased expression fibrotic markers Col1a1, Col3a1, and FSP1. The pro-fibrotic effect of bleomycin on AF cells and BMSCs was in part due to the activation of the TGFβ-TGFβR1-SMAD2/3 signaling pathway. Pharmacological inhibition or gene knock-down of TGFβR1 could mitigate the pro-fibrotic effects.
CONCLUSION: Locally, injection of bleomycin in rats' IVD induced rapid fibrosis and maintained its height through the TGFβ-TGFβR1-SMAD2/3 signaling pathway.

Entities:  

Keywords:  Annulus Fibrosus cells; Bleomycin; Bone marrow stromal cells; Intervertebral disc degeneration; Reparative fibrosis; TGFβ-TGFβR1-SMAD2/3 signaling pathway

Mesh:

Substances:

Year:  2021        PMID: 33413668      PMCID: PMC7791639          DOI: 10.1186/s13287-020-02093-9

Source DB:  PubMed          Journal:  Stem Cell Res Ther        ISSN: 1757-6512            Impact factor:   6.832


  50 in total

Review 1.  Ionizing radiation-induced cellular senescence promotes tissue fibrosis after radiotherapy. A review.

Authors:  Hoang Quy Nguyen; Nhu Hanh To; Patricia Zadigue; Stéphane Kerbrat; Alexandre De La Taille; Sabine Le Gouvello; Yazid Belkacemi
Journal:  Crit Rev Oncol Hematol       Date:  2018-06-22       Impact factor: 6.312

2.  Characterization and restoration of degenerated IVD function with an injectable, in situ gelling alginate hydrogel: An in vitro and ex vivo study.

Authors:  Emily A Growney Kalaf; Meghana Pendyala; J Gary Bledsoe; Scott A Sell
Journal:  J Mech Behav Biomed Mater       Date:  2017-05-07

Review 3.  TGFβ pathway inhibition in the treatment of non-small cell lung cancer.

Authors:  Pınar Ö Eser; Pasi A Jänne
Journal:  Pharmacol Ther       Date:  2017-11-10       Impact factor: 12.310

Review 4.  Specificity and versatility in tgf-beta signaling through Smads.

Authors:  Xin-Hua Feng; Rik Derynck
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

5.  The comet assay: a method to measure DNA damage in individual cells.

Authors:  Peggy L Olive; Judit P Banáth
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis.

Authors:  R K Coker; G J Laurent; S Shahzeidi; P A Lympany; R M du Bois; P K Jeffery; R J McAnulty
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

7.  Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.

Authors:  W Yuan; J Varga
Journal:  J Biol Chem       Date:  2001-08-13       Impact factor: 5.157

8.  Are axial intervertebral disc biomechanics determined by osmosis?

Authors:  Pieter-Paul A Vergroesen; Kaj S Emanuel; Mirte Peeters; Idsart Kingma; Theodoor H Smit
Journal:  J Biomech       Date:  2017-05-08       Impact factor: 2.712

9.  Therapeutic effects of cell therapy with neonatal human dermal fibroblasts and rabbit dermal fibroblasts on disc degeneration and inflammation.

Authors:  Peng Shi; Ana Chee; Weijun Liu; Po-Hsin Chou; Jun Zhu; Howard S An
Journal:  Spine J       Date:  2018-08-22       Impact factor: 4.166

10.  Vimentin coordinates fibroblast proliferation and keratinocyte differentiation in wound healing via TGF-β-Slug signaling.

Authors:  Fang Cheng; Yue Shen; Ponnuswamy Mohanasundaram; Michelle Lindström; Johanna Ivaska; Tor Ny; John E Eriksson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-08       Impact factor: 11.205

View more
  4 in total

1.  Ferulic Acid Combined With Bone Marrow Mesenchymal Stem Cells Attenuates the Activation of Hepatic Stellate Cells and Alleviates Liver Fibrosis.

Authors:  Rui Zhang; Wenhang Li; Xiaodan Jiang; Xinyi Cui; Hongjie You; Zuoqing Tang; Wenlan Liu
Journal:  Front Pharmacol       Date:  2022-05-19       Impact factor: 5.988

Review 2.  Current Perspectives on Nucleus Pulposus Fibrosis in Disc Degeneration and Repair.

Authors:  Yi Sun; Minmin Lyu; Qiuji Lu; Kenneth Cheung; Victor Leung
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

3.  The P2X7 purinergic receptor in intervertebral disc degeneration.

Authors:  Letizia Penolazzi; Leticia S Bergamin; Elisabetta Lambertini; Valentina V Poma; Alba C Sarti; Pasquale De Bonis; Francesco Di Virgilio; Roberta Piva
Journal:  J Cell Physiol       Date:  2021-10-19       Impact factor: 6.513

4.  Application of Bone Marrow Mesenchymal Stem Cells Effectively Eliminates Endotoxemia to Protect Rat from Acute Liver Failure Induced by Thioacetamide.

Authors:  Ting Jiang; Geng Xia; Bo Yang; Hong-Wei Zhang; Yue-Shan Yin; Cheng-Wei Tang; Jin-Hui Yang
Journal:  Tissue Eng Regen Med       Date:  2022-02-05       Impact factor: 4.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.